bPertussis toxin (PT) moves from the host cell surface to the endoplasmic reticulum (ER) by retrograde vesicular transport. The catalytic PTS1 subunit dissociates from the rest of the toxin in the ER and then shifts to a disordered conformation which may trigger its export to the cytosol through the quality control mechanism of ER-associated degradation (ERAD). Functional roles for toxin instability and ERAD in PTS1 translocation have not been established. We addressed these issues with the use of a surface plasmon resonance system to quantify the cytosolic pool of PTS1 from intoxicated cells. Only 3% of surface-associated PTS1 reached the host cytosol after 3 h of toxin exposure. This represented, on average, 38,000 molecules of cytosolic PTS1 per cell. Cells treated with a proteasome inhibitor contained larger quantities of cytosolic PTS1. Stabilization of the dissociated PTS1 subunit with chemical chaperones inhibited toxin export to the cytosol and blocked PT intoxication. ERAD-defective cell lines likewise exhibited reduced quantities of cytosolic PTS1 and PT resistance. These observations identify the unfolding of dissociated PTS1 as a trigger for its ERAD-mediated translocation to the cytosol.
The AB toxins are composed of a catalytic A moiety and a cellbinding B moiety. Some AB toxins move by retrograde vesicular transport from the cell surface to the endosomes, from the endosomes to the Golgi apparatus, and from the Golgi apparatus to the endoplasmic reticulum (ER), where A/B subunit dissociation occurs (1). Unfolding of the dissociated A chain places the toxin in a translocation-competent conformation and activates the host mechanism of ER-associated degradation (ERAD) (2). This quality control system exports misfolded proteins from the ER to the cytosol through protein-conducting channels in the ER membrane (3). ERAD substrates are usually degraded by the cytosolic ubiquitinproteasome system, but the A chains of ER-translocating toxins effectively evade this pathway because they lack the lysine residues required for ubiquitin conjugation (4-7).Pertussis toxin (PT) is an AB 5 -type, ER-translocating toxin (8, 9). Its A subunit, PTS1, disrupts host signaling events through the ADP-ribosylation of G␣ proteins. The B subunit is a hetero-oligomer composed of four proteins (PTS2, PTS3, two copies of PTS4, and PTS5) that bind to specific but largely unidentified glycoconjugates on the host cell (10-14). Holotoxin assembly involves noncovalent positioning of PTS1 above and partially within the central pore of the ring-like PTB oligomer (15). As with other ER-translocating toxins, PT transport from the cell surface to the ER appears to be an inefficient process: fluorescence microscopy, immunoelectron microscopy, and subcellular fractionation can detect internalized toxin in the endosomes and Golgi apparatus but not the ER (16-19). The inhibition of PT intoxication with brefeldin A (BfA), a drug that blocks retrograde vesicular transport to the ER, strongly suggests the functional pool of toxin must move from ...